MPs call for wider NHS access to weight-loss jabs

MPs say plans for only 6% of eligible patients to receive the weight-loss drug Mounjaro on the NHS by 2028 are not ambitious enough. They are urging faster and broader access to the injections. The debate centres on balancing the cost of the drugs against potential long-term health benefits.